Kymera Therapeutics (KYMR) Other Non Operating Income (2019 - 2026)

Kymera Therapeutics (KYMR) has 8 years of Other Non Operating Income data on file, last reported at $15.0 million in Q1 2026.

• On a quarterly basis, Other Non Operating Income rose 69.37% year-over-year to $15.0 million in Q1 2026; TTM through Mar 2026 was $44.2 million, a 18.31% increase from a year earlier, with the FY2025 full-year figure at $38.0 million, up 0.72% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $15.0 million, up from $10.9 million in the prior quarter.
• Over the last five years, Other Non Operating Income for KYMR reached as high as $15.0 million in Q1 2026 and fell as low as $249000.0 in Q1 2022.
• Historically, Other Non Operating Income has averaged $6.8 million across 5 years, with a median of $7.9 million in 2025.
• Across the five-year window, Other Non Operating Income surged 3318.18% in 2022 and slipped 10.38% in 2025, its largest moves.
• Year by year, Other Non Operating Income stood at $3.6 million in 2022, then surged by 40.9% to $5.1 million in 2023, then jumped by 94.61% to $10.0 million in 2024, then increased by 9.12% to $10.9 million in 2025, then jumped by 37.25% to $15.0 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $15.0 million in Q1 2026, $10.9 million in Q4 2025, and $10.3 million in Q3 2025.